EMA Authorised: Paxlovid (nirmatrelvir;ritonavir) — Pfizer Europe MA EEIG

View source ↗

Summary

EMA authorised Paxlovid (nirmatrelvir/ritonavir) for COVID-19 virus infection in Europe.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Disease

Drugs mentioned

• PAXLOVID (Nirmatrelvir and ritonavir)

Snippet

Status: Authorised. Therapeutic area: COVID-19 virus infection. MAH: Pfizer Europe MA EEIG. Decision date: 16/04/2026